1. Home
  2. Stocks
  3. Gls Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Glenmark Life Sciences Share Price Glenmark Life Sciences

    Mid Cap
    ₹814.95
    +64.45 (8.59%)
    28 April, 2024 05:39 BSE: 543322 NSE: GLSISIN: INE03Q201024

    Start SIP in Glenmark Life Sciences

    Start SIP

    Glenmark Life Sciences Performance

    Day Range

    • Low 755
    • High 825
    ₹ 814

    52 Week Range

    • Low 465
    • High 906
    ₹ 814
    • Open Price760
    • Previous Close751
    • Volume584264

    Glenmark Life Sciences Share Price

    • Over 1 Month +7.27%
    • Over 3 Month -2.54%
    • Over 6 Month +32.23%
    • Over 1 Year +75.77%

    Glenmark Life Sciences Key Statistics

    P/E Ratio 21.2
    PEG Ratio 25.2
    Market Cap Cr 9,985
    Price to Book Ratio 4.3
    EPS 38.4
    Dividend 2.8
    Relative Strength Index 53.16
    Money Flow Index 55.2
    MACD Signal 4.75
    Average True Range 38.06
    Glenmark Life Sciences Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 537573595578621
    Operating Expenses Qtr Cr 395400428385415
    Operating Profit Qtr Cr 141173167193206
    Depreciation Qtr Cr 1513131312
    Interest Qtr Cr 00000
    Tax Qtr Cr 3242404751
    Net Profit Qtr Cr 98119119135146
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 2,2952,190
    Operating Expenses Annual Cr 1,6091,519
    Operating Profit Annual in Cr 674642
    Depreciation Cr 5342
    Interest Annual Cr 21
    Tax Annual Cr 160162
    Net Profit Annual Cr 471467
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 414313
    Cash from Investing Activity Annual Cr -116-154
    Cash from Financing Annual Activity Cr -279-388
    Net Cash Flow Annual Cr -228
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 2,3322,138
    Fixed Assets Annual Cr 911842
    Total Non Current Assets Annual Cr 934852
    Total Current Assets Annual Cr 1,9161,850
    Total Assets Annual Cr 2,8502,702
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 190175
    ROE Annual % 2022
    ROCE Annual % 2629
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 3031
    Sign Up to Know More
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin %
    Sign Up to Know More
    Invest in Glenmark Life Sciences

    Glenmark Life Sciences Technicals

    EMA & SMA

    Current Price
    ₹814.95
    +64.45 (8.59%)
    pointer
    • Bullish Moving Average
    • ___
    • 16
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹800.59
    • 50 Day
    • ₹793.62
    • 100 Day
    • ₹765.31
    • 200 Day
    • ₹704.68
    • 20 Day
    • ₹802.70
    • 50 Day
    • ₹806.78
    • 100 Day
    • ₹769.12
    • 200 Day
    • ₹698.58

    Glenmark Life Sciences Resistance and Support

    PIVOT
    ₹798.45
    Resistance
    First Resistance 841.50
    Second Resistance 868.05
    Third Resistance 911.10
    RSI 53.16
    MFI 55.20
    MACD Single Line 4.75
    MACD 4.54
    Support
    First Resistance 771.90
    Second Resistance 728.85
    Third Resistance 702.30

    Glenmark Life Sciences Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 626,896 16,249,144 25.92
    Week 294,860 10,662,130 36.16
    1 Month 140,118 6,612,173 47.19
    6 Month 180,541 10,964,253 60.73

    Glenmark Life Sciences Result Highlights

    Glenmark Life Sciences Synopsis

    NSE-Medical-Ethical Drugs

    Glenmark Life Scienc is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 2283.21 Cr. and Equity Capital is Rs. 24.51 Cr. for the Year ended 31/03/2024. Glenmark Life Sciences Ltd. is a Public Limited Listed company incorporated on 23/06/2011 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L74900PN2011PLC139963 and registration number is 139963.
    Market Cap 9,985
    Sales 2,283
    Shares in Float 2.08
    No of funds 88
    Yield 2.76
    Book Value 4.28
    U/D Vol ratio 1.1
    LTDebt / Equity
    Alpha 0.13
    Beta 0.84

    Glenmark Life Sciences

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 82.85%82.85%82.85%82.85%
    Mutual Funds 0.93%0.59%0.38%0.52%
    Insurance Companies 0.15%
    Foreign Portfolio Investors 5.01%4.57%4.39%3.27%
    Financial Institutions/ Banks
    Individual Investors 9.09%9.2%9.21%10.02%
    Others 2.12%2.79%3.02%3.34%

    Glenmark Life Sciences Management

    Name Designation
    Mr. Glenn Saldanha Chairman & Non-Exe.Director
    Dr. Yasir Rawjee Managing Director & CEO
    Mr. Vinod Naik Executive Director
    Mr. V S Mani Non Executive Director
    Mr. Sridhar Gorthi Independent Director
    Mrs. Manju Agarwal Independent Director
    Mr. Taruvai Laxminarayanan Easwar Independent Director
    Ms. Gita Nayyar Independent Director

    Glenmark Life Sciences Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Glenmark Life Sciences Corporate Action

    Date Purpose Remarks
    2024-04-25 Audited Results
    2024-01-23 Quarterly Results
    2023-10-20 Quarterly Results
    2023-10-09 Interim Dividend
    2023-07-21 Quarterly Results
    Date Purpose Remarks
    2023-10-17 INTERIM Rs.22.50 per share(1125%)Interim Dividend
    2023-03-24 INTERIM Rs.21.00 per share(1050%)Interim Dividend
    2021-11-23 INTERIM Rs.10.50 per share(525%)Interim Dividend

    Glenmark Life Sciences MF Shareholding

    Name Amount(cr)
    Bandhan Small Cap Fund Regular Growth 4,385
    ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth 3,772
    Union Small Cap Fund Regular Growth 3,670
    Union Flexi Cap Fund Growth 1,987
    Nippon India Nifty Smallcap 250 Index Fund Reg Gr 1,093

    Glenmark Life Sciences FAQs

    What is Share Price of Glenmark Life Sciences ?

    Glenmark Life Sciences share price is ₹814 As on 28 April, 2024 | 05:25

    What is the Market Cap of Glenmark Life Sciences ?

    The Market Cap of Glenmark Life Sciences is ₹9985.4 Cr As on 28 April, 2024 | 05:25

    What is the P/E ratio of Glenmark Life Sciences ?

    The P/E ratio of Glenmark Life Sciences is 21.2 As on 28 April, 2024 | 05:25

    What is the PB ratio of Glenmark Life Sciences ?

    The PB ratio of Glenmark Life Sciences is 4.3 As on 28 April, 2024 | 05:25

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.